Trade

with

OraSure Technologies Inc
(NASDAQ: OSUR)
AdChoices
8.12
-0.22
-2.58%
After Hours :
8.12
0.00
0.00%

Open

8.21

Previous Close

8.34

Volume (Avg)

935.70k (542.83k)

Day's Range

7.98-8.51

52Wk Range

5.34-9.58

Market Cap.

454.62M

Dividend Rate ( Yield )

-

Beta

1.71

Shares Outstanding

55.99M

P/E Ratio (EPS)

370.37 (0.02)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Instruments & Supplies
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 98.94M

    • Net Income

    • -11.19M

    • Market Cap.

    • 454.62M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 1.18

    • PEG (Price/Earnings Growth) Ratio

    • 20.85

    • Beta

    • 1.71

    • Forward P/E

    • 416.67

    • Price/Sales

    • 4.38

    • Price/Book Value

    • 2.84

    • Price/Cash flow

    • 64.10

      • EBITDA

      • -5.41M

      • Return on Capital %

      • 0.69

      • Return on Equity %

      • 0.77

      • Return on Assets %

      • 0.69

      • Book Value/Share

      • 2.86

      • Shares Outstanding

      • 55.99M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/17/2014
      Buy
        • 1 Year Price Target

        • 10.50

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • 0.02

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 8.50

          • 10.42

          • Net Income

            YTD/YTD (last year)

          • -

          • -15.59

          • Net Income

            Q/Q (last year)

          • -

          • -8.93

          • Sales (Revenue)

            5-Year Annual Average

          • 6.83

          • 12.51

          • Net Income

            5-Year Annual Average

          • -

          • 4.16

          • Dividends

            5-Year Annual Average

          • -

          • 0.97

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 59.98

            • 52.83

            • Pre-Tax Margin

            • 1.03

            • 15.96

            • Net Profit Margin

            • 1.18

            • 12.40

            • Average Gross Margin

              5-Year Annual Average

            • 62.00

            • 52.66

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -11.70

            • 18.40

            • Average Net Profit Margin

              5-Year Annual Average

            • -10.80

            • 93.46B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.62

              • Current Ratio

              • 7.87

              • 1.97

              • Quick Ratio

              • 6.42

              • 1.16

              • Interest Coverage

              • -

              • 10.47

              • Leverage Ratio

              • 1.12

              • 2.38

              • Book Value/Share

              • 2.86

              • 12.11

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 384.62

                • 34.60

                • P/E Ratio 5-Year High

                • 640.46

                • 279.76

                • P/E Ratio 5-Year Low

                • 145.37

                • 148.87

                • Price/Sales Ratio

                • 4.50

                • 3.21

                • Price/Book Value

                • 2.91

                • 4.00

                • Price/Cash Flow Ratio

                • 64.10

                • 16.67

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 0.77

                    (-7.50)

                  • 17.93

                    (21.42)

                  • Return on Assets %

                    (5-Year Average)

                  • 0.69

                    (-6.30)

                  • 7.35

                    (9.50)

                  • Return on Capital %

                    (5-Year Average)

                  • 0.77

                    (-7.30)

                  • 10.24

                    (13.59)

                  • Income/Employee

                  • 4.16k

                  • 25.65k

                  • Inventory Turnover

                  • 3.22

                  • 2.66

                  • Asset Turnover

                  • 0.58

                  • 0.59

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -12.16M
                  Operating Margin
                  -12.29
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  64.10
                  Ownership

                  Institutional Ownership

                  79.31%

                  Top 10 Institutions

                  45.93%

                  Mutual Fund Ownership

                  39.50%

                  Float

                  71.40%

                  5% / Insider Ownership

                  7.46%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Wells Fargo Advantage Small Cap Value Fd

                  •  

                    4,900,600

                  • -2.17

                  • 8.75

                  • PrimeCap Odyssey Aggressive Growth Fund

                  •  

                    1,523,900

                  • -5.21

                  • 2.72

                  • BlackRock Master Value Opportunities LLC

                  •  

                    1,511,103

                  • 5.88

                  • 2.70

                  • Eaton Vance Worldwide Health Sciences Fu

                  •  

                    1,145,000

                  • 0.00

                  • 2.05

                  • iShares Russell 2000 (AU)

                  •  

                    871,109

                  • -1.00

                  • 1.80

                  • Vanguard Total Stock Mkt Idx

                  •  

                    857,713

                  • 0.00

                  • 1.53

                  • TIAA-CREF Small-Cap Equity

                  •  

                    750,245

                  • 8.41

                  • 1.34

                  • Worldwide Healthcare

                  •  

                    710,000

                  • 0.00

                  • 1.27

                  • Legg Mason Royce US Small Cap Opp

                  •  

                    632,821

                  • 30.48

                  • 1.13

                  • Vanguard Extended Market Index Fund

                  •  

                    623,088

                  • 0.46

                  • 1.11

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Wells Capital Management Inc.

                  •  

                    6,375,689

                  • -13.88%

                  • 11.39

                  • Orbimed Advisors, LLC

                  •  

                    5,372,000

                  • 0.00%

                  • 9.60

                  • BlackRock Advisors LLC

                  •  

                    2,079,534

                  • -18.31%

                  • 3.71

                  • PRIMECAP Management Company

                  •  

                    2,025,400

                  • -6.39%

                  • 3.62

                  • Cortina Asset Management LLC

                  •  

                    2,003,398

                  • +24.38%

                  • 3.58

                  • Columbus Circle Investors

                  •  

                    1,873,510

                  • +1.68%

                  • 3.35

                  • BlackRock Fund Advisors

                  •  

                    1,845,861

                  • -0.86%

                  • 3.30

                  • Vanguard Group, Inc.

                  •  

                    1,743,073

                  • +0.29%

                  • 3.11

                  • Thomson Horstmann & Bryant, Inc.

                  •  

                    1,326,083

                  • +9.55%

                  • 2.37

                  • Tocqueville Asset Management L.P.

                  •  

                    1,062,863

                  • +23.26%

                  • 1.90

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Instruments & Supplies

                  Type

                  Speculative Growth

                  Style

                  Small Growth

                  OraSure Technologies Inc was formed in May 2000 under Delaware law solely for the purposes of combining two companies, STC Technologies, Inc. and Epitope, Inc. and changing the state of incorporation of Epitope from Oregon to Delawar...moree. The Company is engaged in development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its proprietary oral fluid technologies, as well as other diagnostic products including immunoassays and other in vitro diagnostic tests that are used on other specimen types. It also manufactures and sells medical devices used for the removal of benign skin lesions by cryosurgery or freezing. Its diagnostic products include tests that are performed at the point of care and tests that are processed in a laboratory. These produc...morets are sold in the United States and internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities. One of its diagnostic products, the OraQuick In-Home HIV Test got approved by the U.S. FDA for sale in the over-the-counter or consumer retail markets in the United States. Its in vitro diagnostic testing is the process of analyzing oral fluid, blood, urine and other bodily fluids or tissue for the presence of specific substances or markers. Through its subsidiary, DNAG, the Company manufacture and sell kits that are used to collect, stabilize, and store samples of genetic material for molecular testing in the consumer genetics, clinical genetic testing, academic research, pharmacogenomics, personalized medicine, and animal genetics markets. The Company owns rights to trademarks and service marks that are necessary to conduct its business as currently operated. In the United States, it owns the OraSure, Intercept, OraQuick, OraQuick ADVANCE, Histofreezer, OraSure QuickFlu, Q.E.D., Oragene, ORAcollect, OMNIgene, Performagene, PrepIT, HEMAgene, and AUTO-LYTE. The competitors include medical diagnostic companies and specialized biotechnology firms, as well as pharmaceutical companies with biotechnology divisions The Company is subject to other federal and state laws targeting fraud and abuse in the healthcare industry, including false claims laws, marketing conduct laws and laws constraining the sales, marketing and other promotional activities of manufacturers of medical devices by limiting the kinds of financial arrangements, including sales programs, with physicians, hospitals, laboratories and other potential purchasers of medical devices.lessless

                  Key People

                  Douglas A. Michels

                  CEO/Director/President

                  Douglas G. Watson

                  Chairman of the Board/Director

                  Ronald H. Spair

                  CFO/COO/Director

                  Mr. Anthony (Tony) Zezzo, II,

                  Executive VP, Divisional

                  Mr. Ronny B. Lancaster

                  Director

                  • OraSure Technologies Inc

                  • 220 East First Street

                  • Bethlehem, PA 18015

                  • USA.Map

                  • Phone: +1 610 882-1820

                  • Fax: +1 610 882-1830

                  • orasure.com

                  Incorporated

                  2000

                  Employees

                  293

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: